Effects of proportions of dietary macronutrients on glucocorticoid metabolism in diet-induced obesity in rats

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Stimson, Roland H ^a   Lobley, Gerald E ^b   Maraki, Ioanna ^a   Morton, Nicholas M ^a   Andrew, Ruth ^a   Walker, Brian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; MESSENGER RNA; STEROID 5ALPHA REDUCTASE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; CALORIC INTAKE; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOTHESIS; LIPID DIET; LIVER; LOW CARBOHYDRATE DIET; MACRONUTRIENT; MALE; METABOLISM; NONHUMAN; OBESITY; RAT; ANIMAL; DIET; GENETICS;

RATTUS;

ANIMALS; DIET; GLUCOCORTICOIDS; OBESITY; RATS; RNA, MESSENGER; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 77649319107     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008779     Document Type: Article

References (33)

1. Walker BR (2006) Cortisol-cause and cure for metabolic syndrome? Diabet Med 23(12): 1281-1288.
2. Wake DJ, Strand M, Rask E, Westerbacka J, Livingstone DE, et al. (2007) Intraadipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin Endocrinol (Oxf) 66(3): 440-446.
3. Stewart PM, Boulton A, Kumar S, Clark PMS, Shackleton CHL (1999) Cortisol metabolism in human obesity: impaired cortisone - cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 84: 1022-1027.
4. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DEW, et al. (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86(3): 1418-1421.
5. Andrew R, Phillips DIW, Walker BR (1998) Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab 83: 1806-1809.
6. Westerbacka J, Yki-Jarvinen H, Vehkavaara S, Hakkinen AM, Andrew R, et al. (2003) Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. J Clin Endocrinol Metab 88(10): 4924-4931.
7. Sandeep TC, Andrew R, Homer NZ, Andrews RC, Smith K, et al. (2005) Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 54(3): 872-879.
8. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M (2002) Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J Clin Endocrinol Metab 87(6): 2701-2705.
9. Paulsen SK, Pedersen SB, Fisker S, Richelsen B (2007) 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) 15(8): 1954-1960.
10. Livingstone DEW, Jones GC, Smith K, Andrew R, Kenyon CJ, et al. (2000) Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141: 560-563.
11. Livingstone DE, McInnes KJ, Walker BR, Andrew R (2005) Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization. Obes Res 13(9): 1523-1526.
12. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, et al. (1997) Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337(21): 1491-1499.
13. Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, et al. (2005) Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 294(19): 2455-2464.
14. Benedict C, Hallschmid M, Scheibner J, Niemeyer D, Schultes B, et al. (2005) Gut protein uptake and mechanisms of meal-induced cortisol release. J Clin Endocrinol Metab 90(3): 1692-1696.
15. Drake AJ, Livingstone DE, Andrew R, Seckl JR, Morton NM, et al. (2005) Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats. Endocrinology 146(2): 913-919.
16. Morton NM, Ramage L, Seckl JR (2004) Down-regulation of adipose 11betahydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease. Endocrinology 145(6): 2707-2712.
17. Tomlinson JW, Moore JS, Clark PM, Holder G, Shakespeare L, et al. (2004) Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue. J Clin Endocrinol Metab 89(6): 2711-2716.
18. Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Heintze U, et al. (2004) Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 12(1): 9-17.
19. Purnell JQ, Kahn SE, Samuels MH, Brandon D, Loriaux DL, et al. (2009) Enhanced cortisol production rates, free cortisol, and 11{beta}-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss. Am J Physiol Endocrinol Metab 296(2): E351-E357.
20. Stimson RH, Johnstone AM, Homer NZ, Wake DJ, Morton NM, et al. (2007) Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men. J Clin Endocrinol Metab 92(11): 4480-4484.
21. Lobley GE, Bremner DM, Holtrop G, Johnstone AM, Maloney C (2007) Impact of high-protein diets with either moderate or low carbohydrate on weight loss, body composition, blood pressure and glucose tolerance in rats. Br J Nutr 97(6): 1099-1108.
22. Eicheler W, Seitz J, Steinhoff M, Forssmann WG, Adermann K, et al. (1995) Distribution of rat hepatic steroid 5alpha-reductase 1 as shown by immunohistochemistry. Experimental & Clinical Endocrinology & Diabetes 103(2): 105-112.
23. Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM (2002) Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab 87(12): 5630-5635.
24. Goedecke JH, Wake DJ, Levitt NS, Lambert EV, Collins MR, et al. (2006) Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clin Endocrinol (Oxf) 65(1): 81-87.
25. Johnstone AM, Faber P, Andrew R, Gibney ER, Elia M, et al. (2004) Influence of short-term dietary weight loss on cortisol secretion and metabolism in obese men. Eur J Endocrinol 150(2): 185-194.
26. Tomlinson JW, Finney J, Hughes BA, Hughes SV, Stewart PM (2008) Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss. Diabetes 57(6): 1536-1543.
27. Jang C, Obeyesekere VR, Dilley RJ, Krozowski Z, Inder WJ, et al. (2007) Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes. J Clin Endocrinol Metab 92(8): 3314-3320.
28. Hermanowski-Vosatka A, Gerhold D, Mundt SS, Loving VA, Lu M, et al. (2000) PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver. Biochemical & Biophysical Research Communications 279(2): 330-336.
29. Berger J, Tanen M, Elbrecht A, Hermanowski-Vosatka A, Moller DE, et al. (2001) Peroxisome proliferator-activated receptor-c ligands inhibit adipocyte 11b-hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem 276: 12629-12635.
30. Laplante M, Sell H, MacNaul KL, Richard D, Berger JP, et al. (2003) PPARgamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion. Diabetes 52(2): 291-299.
31. Wake DJ, Stimson RH, Tan GD, Homer NZ, Andrew R, et al. (2007) Effects of peroxisome proliferator-activated receptor (PPAR) {alpha} and {gamma} agonists on 11{beta}-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men. J Clin Endocrinol Metab 92(5): 1848-1856.
32. Stulnig TM, Oppermann U, Steffensen KR, Schuster GU, Gustafsson JA (2002) Liver X receptors downregulate 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. Diabetes 51(8): 2426-2433.
33. Liu Y, Yan C, Wang Y, Nakagawa Y, Nerio N, et al. (2006) Liver X receptor agonist T0901317 inhibition of glucocorticoid receptor expression in hepatocytes may contribute to the amelioration of diabetic syndrome in db/db mice. Endocrinology 147(11): 5061-5068.